Clinical

Dataset Information

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma


ABSTRACT: RATIONALE: STI571 may interfere with the growth of cancer cells and may be an effective treatment for soft tissue sarcoma. PURPOSE: Phase I/II trial to study the effectiveness of STI571 in treating patients who have recurrent or refractory soft tissue sarcoma.

DISEASE(S): Endometrial Cancer,Ovarian Cancer,Sarcoma,Small Intestine Cancer,Endometrial Neoplasms,Gastrointestinal Stromal Tumor,Intestinal Neoplasms,Gastrointestinal Stromal Tumors

PROVIDER: 2005389 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR